Amgen Inc., v. Sandoz Inc. 22-1147, - F.4th - (Fed.Cir.Apr. 19, 2023) Jordan is a second-year law student at the University of Missouri and a registered patent agent.He has an extensive background in chemistry and food science.Amgen markets apremilast, a phosphodiesterase-4 ("PDE4") inhibitor, which is used for treating psoriasis and related conditions, under the brand name Otezla® which is covered by three patents, U.S. Patents 7,427,638, 7,893,101, and 10,092,541.
[
add
]
[
|
|
...
]